Repeat transrectal ultrasound-guided prostate biopsy: A strategy to improve the reliability of needle biopsy grading in patients with well- differentiated prostate cancer

Urology

Volumn 52, Issue 4, 1998, Pages 659-662

  Fleshner, Neil E ^a   Cookson, Michael S ^b   Soloway, Scott M ^b   Fair, William R ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0032189487     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00226-X     Document Type: Article

References (6)

1. 1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 47: 239-242, 1997.
2. 2. Cookson MS, Fleshner NE, Soloway SM, et al: Correlation between Gleason score of needle biopsy and radical prostatectomy: accuracy and clinical implications. J Urol 157: 559-563, 1997.
3. 3. Rothman KJ: Modern Epidemiology. Boston, Little, Brown, 1986, pp 100-102.
4. 4. Gleason DF: Histological grading of prostate cancer: a perspective. Human Pathol 23: 273-279, 1992.
5. 5. Thickman D, Speers WC, Philpott PJ, et al: Effect of number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 156: 110-114, 1996.
6. 6. Partin AW, Kattan MW, Subong EN, et al: Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in localized prostate cancer. J Am Med Assoc 277: 1445-1450, 1997.